Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
3.020
-0.147 (-4.64%)
At close: Dec 5, 2025, 4:00 PM EST
3.010
-0.010 (-0.33%)
After-hours: Dec 5, 2025, 6:25 PM EST

Silexion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2013 FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '13 Dec '12
Market Capitalization
9342--
Market Cap Growth
402.04%-92.33%---
Enterprise Value
2641--
Last Close Price
3.0230.151464.75--
PB Ratio
1.35-0.8113.99--
Debt / Equity Ratio
0.29-1.130.06--
Quick Ratio
3.320.342.093.6410.47
Current Ratio
3.970.642.273.8510.64
Return on Equity (ROE)
-771.23%---116.66%-
Return on Assets (ROA)
-77.60%-193.54%--62.13%-
Return on Capital (ROIC)
-130.59%-427.70%--73.07%-
Return on Capital Employed (ROCE)
-103.40%1904.70%-153.00%-195.10%-58.60%
Earnings Yield
-97.93%-510.30%-11.77%--
FCF Yield
-113.70%-261.25%-10.81%--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q